Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0230

NEWS & VIEWS

Neoadjuvant treatment and laparoscopic rectal cancer: Precision genomic medicine essential for improving patient's outcomes.

Seung Hyuk Baik, MD.

Affiliation: Seung Hyuk Baik, MD. Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea.

Tel: +82-2-2228-2100, Fax: +82-2-314-8289, 

E-mail: whitenoja@yuhs.ac

Since there is no abstract available we provide the first paragraph.
Preoperative chemotherapy in selected patients with resectable cancer followed by laparoscopic surgery has become popular in the treatment of low and mid rectal cancer. However, recent reviews and meta-analyses suggest limitations of neoadjuvant treatment based on conventional selection (T3,4 and/or N1,2 tumors). Despite enthusiastic reports for accurate neoadjuvant treatment prediction using microarrays-based gene expression signatures, no such arrays-based predictor has been identified for routine clinical use. Here I discuss the question of safety of laparoscopic rectal cancer resection after neoadjuvant treatment. Moreover, the promise and challenges in discovery of novel biomarkers for rectal cancer based on genome sequencing, mapping and functioning using next-generation sequencing technologies are also reported.

(Citation: Gastric & Breast Cancer 2012; 11(3): 143-145)

Back
You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 July 2012